Amgen Inc.
AMGNAmgen Inc. (AMGN) is a Healthcare company that currently yields 2.22% — historically overvalued based on 10 years of dividend yield history. The Weiss valuation model places the undervaluation threshold at $269.59 and the overvaluation threshold at $348.08. Amgen Inc. holds a quality score of 62/100 (Good), reflecting 13 consecutive years of dividend growth with a 58% payout ratio. The 5-year dividend CAGR stands at 8.3%.
AMGN Dividend Yield History — Weiss Valuation
Distance to undervalued
Entry price is stretched
Needs 39.7% downside to reach the Weiss buy zone
Undervaluation starts near $269.59, where the annual dividend would imply roughly 3.69% yield. That is 1.46% above today's yield.
Buy-zone price
$269.59
Target yield
3.69%
Research checklist
What to clear before buying the yield
Updated Nov 18, 2026
Dividend durability
14YLong dividend history supports a deeper look.
Earnings payout
58%Earnings coverage leaves room for noise.
Cash payout
74%Free cash flow coverage supports the payment.
Dividend growth
8.3%Recent growth adds income compounding potential.
What changed
What changed since the last update
2026-11-17 → 2026-11-18
Price
-2.0%$456.56 → $447.33
Price fell 2.0% since the prior snapshot.
Why Now?
Amgen Inc. is trading near its historical overvaluation band.
Current yield 2.2% vs historical max 3.6% (62% of maximum).
14 consecutive years without a dividend cut.
Conservative payout ratio of 58%.
What matters now
Read the signal before the headline yield
Valuation is the brake here: the yield is compressed versus its own history.
The 62/100 quality score calls for selective follow-up, not autopilot.
Start by checking whether payout coverage and business durability still support the dividend.
AMGN Dividend Income Projection — DRIP Compounder
Dividend Compounder (DRIP)
Year 1 Income
$241
Year 10 Income
$665
Yield on Cost
6.98%
Total Income
$4,151
Assumes dividends reinvested at current price. Simplified model — for illustrative purposes only.
Track actual vs. projected
See what AMGN dividends you actually received with Sharesight
Dividend income log · Yield on cost · DRIP cost basis · Tax reports
More research
Full price history & technical analysis
TradingView ↗Fundamentals, valuation & analyst ratings
FinViz ↗Moat rating & analyst fair value
Morningstar ↗Track dividends received & tax reports
Sharesight ↗AMGN Dividend Quality Score
Quality Score
Good
Key Metrics
Invest in AMGN
Check Amgen Inc. availability and current costs on eToro
Check eToro terms and availability →DividendVisual may earn a commission if you open an account via this link, at no cost to you. Capital at risk. Not financial advice.
In-depth analysis
→ AMGN Dividend Analysis Article